Don’t have an account?
Select the donation type you’d like to make
A/Prof Denese C. Marks
Research Program Leader- Product Development and Transfusion Studies
Associate Professor, School of Medicine, The University of Sydney
Connect with A/Prof Marks
Denese leads the Product Development team and has over 25 years’ research experience. She holds an adjunct appointment with the School of Medicine, University of Sydney. Her research focuses on improving blood component processing and storage, including donor attributes that may influence blood component quality, and clinical trials of new blood products.
She has over 100 peer-reviewed publications and holds international leadership roles with the Biomedical Excellence for Safer Transfusion (BEST) Collaborative, and the International Society of Blood Transfusion.
Awards
- Australian and New Zealand Society of Blood Transfusion (ANZSBT) grant
- Chief Investigator on two NHMRC-funded clinical trial grants
- Chief Investigator on an Australian Research Council grant
- Chief investigator on a Medical Research Future Fund grant
Leadership
- Chair of the ISBT Working Party for Blood Components
- Executive committee of ISBT Cellular Therapies Working Party
- Vox Sanguinis section editor for Blood Component Collection and Processing
- Team leader of the BEST Collaborative Conventional Components Team
- Reviewer for journals including Transfusion, Vox Sanguinis, Platelets, Journal of Transfusion and Apheresis Science, and Journal of Proteomics
- Abstract reviewer for ISBT and AABB conference submissions
Key publications
Risk factors for T-cell lymphopenia in frequent platelet donors: The BEST collaborative study.
2023
Transfusion
63:2072-2082.
X- and gamma-irradiation have similar effects on the in vitro quality of stored red cell components.
2021
Transfusion
61(11):3214-3223
Platelet lysate can support the development of a 3D-engineered skin for clinical application.
2023
Cell Tissue Res.
391:173-188.
A randomized, controlled pilot clinical trial of cryopreserved platelets for perioperative surgical bleeding: the CLIP-I trial (Editorial, p. 2759)
2019
Transfusion
59:2794-2804.
Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies.
2023
Vox Sanguinis
118:301-309.
A/Prof Denese Marks articles
